|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.645
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.552
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.540
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.518
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.476
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.463
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.461
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.451
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.447
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.431
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.429
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.415
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.406
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.376
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.367
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.364
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.347
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.345
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.342
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.330
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.327
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.324
|
|
|
|
cd4 positive alpha beta t cell cytokine production
|
GO:0035743 |
4 |
0.320
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.315
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.307
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.304
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.296
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.289
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.284
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.278
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.274
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.264
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.246
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.246
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.242
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.237
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.235
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.227
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.226
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.220
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.217
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.215
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.208
|
|
|
|
t helper 2 cell cytokine production
|
GO:0035745 |
4 |
0.207
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.203
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.197
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.192
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.191
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.188
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.188
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.185
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.184
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.181
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.177
|
|
|
|
negative regulation of muscle cell differentiation
|
GO:0051148 |
33 |
0.173
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.171
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.171
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.170
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.167
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.165
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.164
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.163
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.161
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.157
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.156
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.155
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.155
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.154
|
|
|
|
positive regulation of cell division
|
GO:0051781 |
31 |
0.152
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.151
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.151
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.150
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.149
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.149
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.149
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.148
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.147
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.147
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.147
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.146
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.145
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.138
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.137
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.135
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.132
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.132
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.132
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.129
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.129
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.128
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.128
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.128
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.128
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.127
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.126
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.124
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.123
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.123
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.121
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.119
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.119
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.119
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.117
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.117
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.115
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.114
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.113
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.113
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.112
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.111
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.110
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.109
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.108
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.108
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.108
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.107
|
|
|
|
regulation of t helper 2 cell cytokine production
|
GO:2000551 |
3 |
0.107
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.107
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.107
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.107
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.106
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.106
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.106
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.106
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.106
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.106
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.105
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.104
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.104
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.104
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.103
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.103
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.102
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.102
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.101
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.100
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.100
|
|
|
|
forebrain neuron development
|
GO:0021884 |
30 |
0.099
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.099
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.099
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.098
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.097
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.097
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.095
|
|
|
|
negative regulation of myoblast differentiation
|
GO:0045662 |
18 |
0.094
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.094
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.093
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.093
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.092
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
42 |
0.092
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.092
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.091
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.091
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.091
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.090
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.090
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.090
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.090
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.090
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.089
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.089
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.089
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.088
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.088
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.086
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.086
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.086
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.086
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.086
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.085
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.084
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.084
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.084
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.083
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.082
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.081
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.081
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.081
|
|
|
|
learning
|
GO:0007612 |
98 |
0.080
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.080
|
|
|
|
positive regulation of branching involved in ureteric bud morphogenesis
|
GO:0090190 |
18 |
0.080
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.079
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.079
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.079
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.079
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.078
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.078
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.077
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.077
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.077
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.077
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.077
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.077
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.076
|
|
|
|
interleukin 13 secretion
|
GO:0072611 |
2 |
0.076
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.076
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.076
|
|
|
|
positive regulation of nuclear division
|
GO:0051785 |
27 |
0.076
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.075
|
|
|
|
metanephric nephron morphogenesis
|
GO:0072273 |
19 |
0.075
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.074
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.074
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.074
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.074
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.074
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.073
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.072
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.072
|
|
|
|
regulation of mesonephros development
|
GO:0061217 |
24 |
0.072
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.072
|
|
|
|
positive regulation of jun kinase activity
|
GO:0043507 |
30 |
0.071
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.071
|
|
|
|
interleukin 5 secretion
|
GO:0072603 |
2 |
0.071
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.071
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.070
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.070
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.070
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.070
|
|
|
|
regulation of interleukin 13 secretion
|
GO:2000665 |
2 |
0.070
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.070
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.070
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.069
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.069
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.069
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.069
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.069
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.069
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.068
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.068
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.068
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.067
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.067
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.066
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
24 |
0.066
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.066
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.066
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.066
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.066
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.066
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.065
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.065
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.064
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.064
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.064
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.063
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.063
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.063
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.063
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.062
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.062
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.061
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.061
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.060
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.060
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.060
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.060
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.060
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.060
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.059
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.059
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.059
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.058
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.058
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.058
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.058
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.057
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.057
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.057
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.057
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.056
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.056
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.056
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.056
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.056
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.056
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.056
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.056
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.056
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.056
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.056
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.055
|
|
|
|
chloride transmembrane transport
|
GO:1902476 |
24 |
0.055
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.055
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.055
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.055
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.054
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
22 |
0.054
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.054
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.054
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.054
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.054
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.053
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.053
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.053
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.053
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.053
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.053
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.053
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.052
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.052
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.052
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.052
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.051
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.051
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.051
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.051
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.050
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.050
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.050
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.050
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.050
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.049
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.049
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.049
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.049
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.049
|
Rat |
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.049
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.049
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.049
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
20 |
0.049
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.049
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.049
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.049
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.048
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.048
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.048
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.048
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.048
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.048
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.047
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.047
|
|
|
|
regulation of cytokine production involved in immune response
|
GO:0002718 |
26 |
0.047
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.047
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.047
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.046
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.046
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.046
|
|
|
|
regulation of interleukin 5 secretion
|
GO:2000662 |
2 |
0.046
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.046
|
Rat |
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.046
|
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
27 |
0.045
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.045
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.045
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.045
|
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.045
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.045
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.045
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.044
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.044
|
|
|
|
positive regulation of neuroblast proliferation
|
GO:0002052 |
19 |
0.044
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.044
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.044
|
|
|
|
g protein coupled receptor internalization
|
GO:0002031 |
3 |
0.044
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.044
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.044
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.044
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.044
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.044
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.044
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.044
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.044
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.044
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.043
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.043
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.043
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.042
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.042
|
|
|
|
chloride transport
|
GO:0006821 |
32 |
0.042
|
|
|
|
metanephric tubule development
|
GO:0072170 |
18 |
0.042
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.042
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.042
|
|
|
|
metanephric nephron epithelium development
|
GO:0072243 |
19 |
0.042
|
|
|
|
regulation of metanephros development
|
GO:0072215 |
15 |
0.042
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.042
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.042
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.042
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.042
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.041
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.041
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.041
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.041
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.041
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.041
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.041
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.041
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.041
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.041
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.040
|
|
|
|
negative regulation of interleukin 5 secretion
|
GO:2000663 |
1 |
0.040
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.040
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.040
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.040
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.040
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.040
|
|
|
|
regulation of lyase activity
|
GO:0051339 |
13 |
0.040
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.039
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.039
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.039
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.039
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.039
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.039
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.039
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.039
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.039
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.039
|
|
|
|
negative regulation of interleukin 13 production
|
GO:0032696 |
2 |
0.039
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.038
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.038
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.038
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.038
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.038
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.038
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.038
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.038
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.038
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.038
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.038
|
|
|
|
detection of stimulus involved in sensory perception
|
GO:0050906 |
44 |
0.038
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.038
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.038
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.037
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.037
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.037
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.037
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.037
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.037
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.037
|
Rat |
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.037
|
|
|
|
epithelial cell maturation
|
GO:0002070 |
15 |
0.037
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.037
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.037
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.036
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.036
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.036
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.036
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.036
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.036
|
|
|
|
reflex
|
GO:0060004 |
22 |
0.036
|
|
|
|
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis
|
GO:0072108 |
3 |
0.036
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.036
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.036
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.036
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.036
|
|
|
|
thyroid hormone metabolic process
|
GO:0042403 |
16 |
0.035
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.035
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.035
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.035
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.035
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.035
|
|
|
|
positive regulation of t helper 1 cell differentiation
|
GO:0045627 |
4 |
0.035
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.035
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.035
|
|
|
|
dopaminergic neuron differentiation
|
GO:0071542 |
14 |
0.035
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.035
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.035
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.035
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.035
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.035
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.035
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.035
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.035
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.034
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.034
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.034
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.034
|
|
|
|
negative regulation of interleukin 13 secretion
|
GO:2000666 |
1 |
0.034
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.034
|
Rat |
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.034
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.034
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.034
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.034
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.034
|
|
|
|
epithelial cell maturation involved in prostate gland development
|
GO:0060743 |
4 |
0.033
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.033
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.033
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.033
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.033
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.033
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.033
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.033
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.033
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.033
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.033
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.033
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.033
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.033
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.033
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.033
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.033
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.033
|
|
|
|
positive regulation of myoblast differentiation
|
GO:0045663 |
8 |
0.033
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.033
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.032
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.032
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.032
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
29 |
0.032
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.032
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.032
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.032
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.032
|
|